Essex LLC’s Bristol-Myers Squibb BMY Stock Holding History

Essex LLC’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-8,373	Closed	-$350K	–	170
2024 Q2	$350K	Sell	8,373 -249	-3%	-$11.1K	0.08%	119
2024 Q1	$467K	Sell	8,622 -715	-8%	-$36.4K	0.11%	103
2023 Q4	$478K	Sell	9,337 -1,215	-12%	-$63.8K	0.12%	106
2023 Q3	$614K	Sell	10,552 -2,238	-17%	-$137K	0.17%	94
2023 Q2	$818K	Sell	12,790 -2,479	-16%	-$166K	0.23%	88
2023 Q1	$1.1M	Hold	15,269	–	–	0.33%	77
2022 Q4	$1.1M	Sell	15,269 -827	-5%	-$62.4K	0.33%	77
2022 Q3	$1.14M	Sell	16,096 -18,514	-53%	-$1.34M	0.38%	69
2022 Q2	$2.67M	Sell	34,610 -178	-0.5%	-$13.6K	0.83%	41
2022 Q1	$2.54M	Buy	34,788 +617	+2%	+$41.4K	0.69%	50
2021 Q4	$2.13M	Buy	34,171 +3,705	+12%	+$217K	0.57%	58
2021 Q3	$1.8M	Buy	+30,466	New	+$2.01M	0.5%	64

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Essex LLC's BMY Position: Q3 2024 in Review

Essex LLC sold out of Bristol-Myers Squibb (BMY) in Q3 2024, closing a stake of 8,373 shares — an estimated $350K sold.

Essex LLC first reported a position in BMY in Q3 2021 and held it in 12 quarters. The position peaked at $2.67M in Q2 2022. 2,263 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

Essex LLC reported no remaining Bristol-Myers Squibb position as of Q3 2024 after selling out during the quarter.
Essex LLC sold 8,373 Bristol-Myers Squibb shares in Q3 2024, an estimated $350K.
Essex LLC first reported a position in Bristol-Myers Squibb in Q3 2021 and held it in 12 quarters.
Essex LLC's Bristol-Myers Squibb position peaked at $2.67M in Q2 2022.
2,263 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on Essex LLC's 13F filing for Q3 2024, filed 18 Oct 2024.